Atossa Therapeutics Inc (ATOS)
1.66
+0.14
(+9.21%)
USD |
NASDAQ |
May 03, 16:00
1.66
0.00 (0.00%)
After-Hours: 20:00
Atossa Therapeutics Price: 1.66 for May 3, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| May 03, 2024 | 1.53 | 1.70 | 1.53 | 1.66 | 1.357M |
| May 02, 2024 | 1.54 | 1.57 | 1.49 | 1.52 | 1.218M |
| May 01, 2024 | 1.51 | 1.54 | 1.47 | 1.53 | 967983.0 |
| Apr 30, 2024 | 1.53 | 1.585 | 1.47 | 1.51 | 1.452M |
| Apr 29, 2024 | 1.57 | 1.58 | 1.52 | 1.53 | 1.048M |
| Apr 26, 2024 | 1.58 | 1.595 | 1.51 | 1.53 | 900111.0 |
| Apr 25, 2024 | 1.48 | 1.57 | 1.45 | 1.52 | 854598.0 |
| Apr 24, 2024 | 1.48 | 1.595 | 1.48 | 1.50 | 2.338M |
| Apr 23, 2024 | 1.41 | 1.51 | 1.41 | 1.49 | 1.219M |
| Apr 22, 2024 | 1.32 | 1.47 | 1.32 | 1.42 | 1.021M |
| Apr 19, 2024 | 1.43 | 1.43 | 1.33 | 1.37 | 1.213M |
| Apr 18, 2024 | 1.31 | 1.48 | 1.24 | 1.42 | 2.324M |
| Apr 17, 2024 | 1.54 | 1.619 | 1.35 | 1.35 | 4.115M |
| Apr 16, 2024 | 1.67 | 1.69 | 1.53 | 1.54 | 1.719M |
| Apr 15, 2024 | 1.63 | 1.73 | 1.63 | 1.71 | 1.606M |
| Apr 12, 2024 | 1.83 | 1.83 | 1.595 | 1.66 | 2.011M |
| Apr 11, 2024 | 1.77 | 1.84 | 1.74 | 1.77 | 1.008M |
| Apr 10, 2024 | 1.79 | 1.82 | 1.72 | 1.75 | 1.642M |
| Apr 09, 2024 | 1.76 | 1.97 | 1.70 | 1.84 | 3.864M |
| Apr 08, 2024 | 1.85 | 1.91 | 1.63 | 1.75 | 4.052M |
| Apr 05, 2024 | 2.17 | 2.31 | 1.60 | 1.87 | 10.59M |
| Apr 04, 2024 | 2.04 | 2.27 | 2.025 | 2.10 | 4.025M |
| Apr 03, 2024 | 1.84 | 2.07 | 1.810 | 2.025 | 2.384M |
| Apr 02, 2024 | 2.00 | 2.04 | 1.82 | 1.84 | 3.559M |
| Apr 01, 2024 | 1.84 | 2.11 | 1.78 | 2.00 | 3.429M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
0.502
Minimum
Dec 28 2022
8.62
Maximum
Jun 25 2021
1.753
Average
1.42
Median
Nov 13 2019
Price Benchmarks
| AngioDynamics Inc | 6.27 |
| Achieve Life Sciences Inc | 4.735 |
| Biolase Inc | 0.1451 |
| Outset Medical Inc | 3.14 |
| Perspective Therapeutics Inc | 1.81 |
Price Related Metrics
| Price to Book Value | 2.285 |
| Earnings Yield | -14.46% |
| Market Cap | 208.00M |